UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 68

Sortiert nach

High antibody titer in an adult with Pompe disease affects treatment with alglucosidase alfa

Molecular genetics and metabolism, 2010-12, Vol.101 (4), p.338-345

2010

Volltextzugriff (PDF)

Pre-existing Antibody: Biotherapeutic Modality-Based Review

The AAPS journal, 2016-03, Vol.18 (2), p.311-320

2016

Volltextzugriff (PDF)

Liquid chromatography-tandem mass spectrometry quantification of globotriaosylceramide in plasma for long-term monitoring of fabry patients treated with enzyme replacement therapy

Clinical chemistry (Baltimore, Md.), 2005, Vol.51 (1), p.237-240

2005

Volltextzugriff (PDF)

Letter to the Editors: Concerning “CRIM-negative Pompe disease patients with satisfactory clinical outcomes on enzyme replacement therapy” by Al Khallaf et al

Journal of inherited metabolic disease, 2014-01, Vol.37 (1), p.141-143

2014

Volltextzugriff (PDF)

Enhancement of human plasma glucosylceramide assay sensitivity using delipidized plasma

Molecular genetics and metabolism reports, 2016-09, Vol.8 (C), p.77-79

2016

Volltextzugriff (PDF)

Validation of a HLA-A2 tetramer flow cytometric method, IFNgamma real time RT-PCR, and IFNgamma ELISPOT for detection of immunologic response to gp100 and MelanA/MART-1 in melanoma patients

Journal of translational medicine, 2008-10, Vol.6 (1), p.61-61, Article 61

2008

Volltextzugriff (PDF)

Globotriaosylceramide isoform profiles in human plasma by liquid chromatography–tandem mass spectrometry

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2004-06, Vol.805 (1), p.127-134

2004

Volltextzugriff (PDF)

Galactosylsphingosine does not interfere with the quantitation of plasma glucosylsphingosine levels in Gaucher patients

Clinica chimica acta, 2019-07, Vol.494, p.48-51

2019

Volltextzugriff (PDF)

Development and validation of a novel multiplex LC-MS/MS assay of globotriaosylceramide and globotriaosylsphingosine in human plasma

Molecular genetics and metabolism, 2019-02, Vol.126 (2), p.S39-S40

2019

Volltextzugriff (PDF)

Agalsidase-beta therapy for advanced Fabry disease: a randomized trial

Annals of internal medicine, 2007-01, Vol.146 (2), p.77

2007

Volltextzugriff (PDF)

Recommendations for the Assessment and Management of Pre-existing Drug-Reactive Antibodies During Biotherapeutic Development

The AAPS journal, 2017-11, Vol.19 (6), p.1576-1586

2017

Volltextzugriff (PDF)

A retrospective analysis of the potential impact of IgG antibodies to agalsidase β on efficacy during enzyme replacement therapy for Fabry disease

Molecular genetics and metabolism, 2009, Vol.96 (1), p.4-12

2009

Volltextzugriff (PDF)

Alglucosidase alfa inhibitory antibodies and clinical correlates in treatment-naive late-onset Pompe disease patients in the late-onset treatment study (LOTS) over 78 weeks: A new post hoc analysis

Molecular genetics and metabolism, 2019-02, Vol.126 (2), p.S146-S147

2019

Volltextzugriff (PDF)

An immune tolerance approach using methotrexate in the naïve setting of patients treated with a therapeutic protein: Experience in infantile Pompe disease

Molecular genetics and metabolism, 2018-02, Vol.123 (2), p.S38-S38

2018

Volltextzugriff (PDF)

Pharmacokinetic and pharmacodynamic studies of two different rabbit antithymocyte globulin dosing regimens: Results of a randomized trial

Transplant immunology, 2013-03, Vol.28 (2), p.120-126

2013

Volltextzugriff (PDF)

A novel approach for quantitation of glucosylceramide in human dried blood spot using LC-MS/MS

Bioanalysis, 2015-01, Vol.7 (12), p.1483-1496

2015

Volltextzugriff (PDF)

Conditional modeling of antibody titers using a zero-inflated poisson random effects model: application to Fabrazyme

Journal of pharmacokinetics and pharmacodynamics, 2009-10, Vol.36 (5), p.443-459

2009

Volltextzugriff (PDF)

Alemtuzumab can be Incorporated Into Front-Line Therapy of Adult Acute Lymphoblastic Leukemia (ALL): Final Phase I Results of a Cancer and Leukemia Group B Study (CALGB 10102)

Blood, 2009-11, Vol.114 (22), p.838-838

2009

Volltextzugriff (PDF)

Healthcare worker stress, anxiety and burnout during the COVID-19 pandemic in Singapore: A 6-month multi-centre prospective study

PloS one, 2021-10, Vol.16 (10), p.e0258866-e0258866

2021

Volltextzugriff (PDF)

Functional activation of pyruvate dehydrogenase in human brain using hyperpolarized [1- 13 C]pyruvate

Magnetic resonance in medicine, 2024-05, Vol.91 (5), p.1822-1833

2024

Volltextzugriff (PDF)

Comparison of sample preparation approaches and validation of an extraction method for nitrosatable pesticides and metabolites in human serum and urine analyzed by liquid chromatography – Orbital ion trap mass spectrometry

Journal of Chromatography A, 2019-10, Vol.1603, p.83-91

2019

Volltextzugriff (PDF)

Deep-learning-based cardiovascular risk stratification using coronary artery calcium scores predicted from retinal photographs

The Lancet. Digital health, 2021-05, Vol.3 (5), p.e306-e316

2021

Volltextzugriff (PDF)

Global Sources of Fine Particulate Matter: Interpretation of PM2.5 Chemical Composition Observed by SPARTAN using a Global Chemical Transport Model

Environmental science & technology, 2018-10, Vol.52 (20), p.11670-11681

2018

Volltextzugriff (PDF)

Retinal photograph-based deep learning predicts biological age, and stratifies morbidity and mortality risk

Age and ageing, 2022-04, Vol.51 (4)

2022

Volltextzugriff (PDF)

1 – 25 von 68

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(64)

Publikationsform

Artikel
(67)
Tagungsberichte
(1)

Sprache

Englisch
(68)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

Science & Technology
(45)
Life Sciences & Biomedicine
(41)
Humans
(29)
Male
(16)
Female
(15)
Biological And Medical Sciences
(10)
Middle Aged
(9)
Adult
(8)
Animals
(7)
Medical Sciences
(7)
Pharmacy
(7)
Fundamental And Applied Biological Sciences. Psychology
(6)
Genetics & Heredity
(6)
Medicine, Research & Experimental
(6)
Research & Experimental Medicine
(6)
Aged
(5)
Biochemistry & Molecular Biology
(5)
Immunology
(5)
Alpha-Galactosidase - Therapeutic Use
(4)
Biochemistry
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

High antibody titer in an adult with Pompe disease affects treatment with alglucosidase alfa

Pre-existing Antibody: Biotherapeutic Modality-Based Review

Liquid chromatography-tandem mass spectrometry quantification of globotriaosylceramide in plasma for long-term monitoring of fabry patients treated with enzyme replacement therapy

Letter to the Editors: Concerning “CRIM-negative Pompe disease patients with satisfactory clinical outcomes on enzyme replacement therapy” by Al Khallaf et al

Enhancement of human plasma glucosylceramide assay sensitivity using delipidized plasma

Validation of a HLA-A2 tetramer flow cytometric method, IFNgamma real time RT-PCR, and IFNgamma ELISPOT for detection of immunologic response to gp100 and MelanA/MART-1 in melanoma patients

Globotriaosylceramide isoform profiles in human plasma by liquid chromatography–tandem mass spectrometry

Galactosylsphingosine does not interfere with the quantitation of plasma glucosylsphingosine levels in Gaucher patients

Development and validation of a novel multiplex LC-MS/MS assay of globotriaosylceramide and globotriaosylsphingosine in human plasma

Agalsidase-beta therapy for advanced Fabry disease: a randomized trial

Recommendations for the Assessment and Management of Pre-existing Drug-Reactive Antibodies During Biotherapeutic Development

An immune tolerance approach using transient low-dose methotrexate in the ERT-naïve setting of patients treated with a therapeutic protein: experience in infantile-onset Pompe disease

A retrospective analysis of the potential impact of IgG antibodies to agalsidase β on efficacy during enzyme replacement therapy for Fabry disease

Alglucosidase alfa inhibitory antibodies and clinical correlates in treatment-naive late-onset Pompe disease patients in the late-onset treatment study (LOTS) over 78 weeks: A new post hoc analysis

An immune tolerance approach using methotrexate in the naïve setting of patients treated with a therapeutic protein: Experience in infantile Pompe disease

Pharmacokinetic and pharmacodynamic studies of two different rabbit antithymocyte globulin dosing regimens: Results of a randomized trial

A novel approach for quantitation of glucosylceramide in human dried blood spot using LC-MS/MS

Conditional modeling of antibody titers using a zero-inflated poisson random effects model: application to Fabrazyme

Alemtuzumab can be Incorporated Into Front-Line Therapy of Adult Acute Lymphoblastic Leukemia (ALL): Final Phase I Results of a Cancer and Leukemia Group B Study (CALGB 10102)

Healthcare worker stress, anxiety and burnout during the COVID-19 pandemic in Singapore: A 6-month multi-centre prospective study

Functional activation of pyruvate dehydrogenase in human brain using hyperpolarized [1- 13 C]pyruvate

Comparison of sample preparation approaches and validation of an extraction method for nitrosatable pesticides and metabolites in human serum and urine analyzed by liquid chromatography – Orbital ion trap mass spectrometry

Deep-learning-based cardiovascular risk stratification using coronary artery calcium scores predicted from retinal photographs

Global Sources of Fine Particulate Matter: Interpretation of PM2.5 Chemical Composition Observed by SPARTAN using a Global Chemical Transport Model

Retinal photograph-based deep learning predicts biological age, and stratifies morbidity and mortality risk

Suchergebnisse filtern